Germline mutations in BRCA1 and BRCA2 are associated with greatly increased frequency of breast and ovarian cancers and telomere shortening was associated with genetic anticipation in hereditary breast cancer [38]. The gene discussed is BRCA2; the disease is ovarian carcinoma.